{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:54Z","timestamp":1793155734372,"version":"4.5.0"},"reference-count":241,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Multiple myeloma (MM) is an incapacitating hematological malignancy characterized by accumulation of cancerous plasma cells in the bone marrow (BM) and production of an abnormal monoclonal protein (M-protein). The BM microenvironment has a key role in myeloma development by facilitating the growth of the aberrant plasma cells, which eventually interfere with the homeostasis of the bone cells, exacerbating osteolysis and inhibiting osteoblast differentiation. Recent recognition that metabolic reprograming has a major role in tumor growth and adaptation to specific changes in the microenvironmental niche have led to consideration of the role of sphingolipids and the enzymes that control their biosynthesis and degradation as critical mediators of cancer since these bioactive lipids have been directly linked to the control of cell growth, proliferation, and apoptosis, among other cellular functions. In this review, we present the recent progress of the research investigating the biological implications of sphingolipid metabolism alterations in the regulation of myeloma development and its progression from the pre-malignant stage and discuss the roles of sphingolipids in in MM migration and adhesion, survival and proliferation, as well as angiogenesis and invasion. We introduce the current knowledge regarding the role of sphingolipids as mediators of the immune response and drug-resistance in MM and tackle the new developments suggesting the manipulation of the sphingolipid network as a novel therapeutic direction for MM.<\/jats:p>","DOI":"10.3389\/fonc.2022.925807","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T04:54:27Z","timestamp":1654664067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets"],"prefix":"10.3389","volume":"12","author":[{"given":"Daniela N.","family":"Petrusca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Galson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09837","article-title":"Initial Genome Sequencing and Analysis of Multiple Myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14889","article-title":"Therapeutic Targets in Myeloma Bone Disease","volume":"178","author":"Marino","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.01.006","article-title":"Navigating the Role of CD1d\/Invariant Natural Killer T-Cell\/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications","volume":"20","author":"Papoutselis","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436220","article-title":"Clinical Drug Resistance Linked to Interconvertible Phenotypic and Functional States of Tumor-Propagating Cells in Multiple Myeloma","volume":"121","author":"Chaidos","year":"2013","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2013006061","article-title":"Gaucher Disease and Myeloma","volume":"18","author":"Ayto","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher Disease and Cancer Incidence: A Study From the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid Metabolism in Cancer Signalling and Therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2010.10.003","article-title":"Sphingolipids and Expression Regulation of Genes in Cancer","volume":"50","author":"Patwardhan","year":"2011","journal-title":"Prog Lipid Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13063","article-title":"Sphingolipid Metabolism in the Development and Progression of Cancer: One Cancer's Help Is Another's Hindrance","volume":"15","author":"Piazzesi","year":"2021","journal-title":"Mol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2217\/fon.10.116","article-title":"Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance","volume":"6","author":"Ponnusamy","year":"2010","journal-title":"Future Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-35582-1_7","article-title":"S1P Signaling in the Tumor Microenvironment","volume":"1223","author":"Schneider","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R046656","article-title":"Export of Sphingosine-1-Phosphate and Cancer Progression","volume":"55","author":"Takabe","year":"2014","journal-title":"J Lipid Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500313-JLR200","article-title":"Substrate Specificity of Human Ceramide Kinase","volume":"46","author":"Wijesinghe","year":"2005","journal-title":"J Lipid Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2005.04.006","article-title":"The Ins and Outs of Sphingolipid Synthesis","volume":"15","author":"Futerman","year":"2005","journal-title":"Trends Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R200009200","article-title":"De Novo Sphingolipid Biosynthesis: A Necessary, But Dangerous, Pathway","volume":"277","author":"Merrill","year":"2002","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400208","article-title":"The Complex Life of Simple Sphingolipids","volume":"5","author":"Futerman","year":"2004","journal-title":"EMBO Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2329","article-title":"Principles of Bioactive Lipid Signalling: Lessons From Sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0962-8924(99)01694-3","article-title":"Ceramide in the Eukaryotic Stress Response","volume":"10","author":"Hannun","year":"2000","journal-title":"Trends Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745092","article-title":"Targeting Sphingolipids for Cancer Therapy","volume":"11","author":"Companioni","year":"2021","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R200008200","article-title":"The Ceramide-Centric Universe of Lipid-Mediated Cell Regulation: Stress Encounters of the Lipid Kind","volume":"277","author":"Hannun","year":"2002","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600010200","article-title":"When do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?: Insights Into the Regulation of Ceramide Synthesis","volume":"281","author":"Pewzner-Jung","year":"2006","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-000-0627-6","article-title":"Further Characterization of Rat Dihydroceramide Desaturase: Tissue Distribution, Subcellular Localization, and Substrate Specificity","volume":"35","author":"Causeret","year":"2000","journal-title":"Lipids"},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1139\/o03-091","article-title":"Acid and Neutral Sphingomyelinases: Roles and Mechanisms of Regulation","volume":"82","author":"Marchesini","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/B:GLYC.0000046272.38480.ef","article-title":"Glycosphingolipidoses: Beyond the Enzymatic Defect","volume":"21","author":"Raas-Rothschild","year":"2004","journal-title":"Glycoconj J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600021200","article-title":"The Multigenic Sphingomyelin Synthase Family","volume":"281","author":"Tafesse","year":"2006","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/cells9061379","article-title":"Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration","volume":"9","author":"Duarte","year":"2020","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.08.007","article-title":"Sphingosine Kinases, Sphingosine 1-Phosphate, Apoptosis and Diseases","volume":"1758","author":"Hait","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B28","doi-asserted-by":"publisher","first-page":"109806","DOI":"10.1016\/j.cellsig.2020.109806","article-title":"Structure-Function Analysis of Lipid Substrates and Inhibitors of Sphingosine Kinases","volume":"76","author":"Adams","year":"2020","journal-title":"Cell Signal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.10.061","article-title":"The Spinster Homolog, Two of Hearts, is Required for Sphingosine 1-Phosphate Signaling in Zebrafish","volume":"18","author":"Osborne","year":"2008","journal-title":"Curr Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.09.021","article-title":"The Transporter Spns2 is Required for Secretion of Lymph But Not Plasma Sphingosine-1-Phosphate","volume":"2","author":"Mendoza","year":"2012","journal-title":"Cell Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is Essential for the Sphingosine-1-Phosphate Export in Erythrocytes and Platelets","volume":"550","author":"Vu","year":"2017","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.S091959","article-title":"New Insights Into Functions of the Sphingosine-1-Phosphate Transporter SPNS2","volume":"60","author":"Spiegel","year":"2019","journal-title":"J Lipid Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-261289","article-title":"Sphingosine 1-Phosphate is a Ligand for Peroxisome Proliferator-Activated Receptor-Gamma That Regulates Neoangiogenesis","volume":"29","author":"Parham","year":"2015","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1504555113","article-title":"ER Stress Stimulates Production of the Key Antimicrobial Peptide, Cathelicidin, by Forming a Previously Unidentified Intracellular S1P Signaling Complex","volume":"113","author":"Park","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-Phosphate Is a Missing Cofactor for the E3 Ubiquitin Ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/cancers14030772","article-title":"GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival","volume":"14","author":"Petrusca","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.316298","article-title":"Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies","volume":"127","author":"Xie","year":"2020","journal-title":"Circ Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"ra58","DOI":"10.1126\/scisignal.aaa4998","article-title":"Binding of the Sphingolipid S1P to hTERT Stabilizes Telomerase at the Nuclear Periphery by Allosterically Mimicking Protein Phosphorylation","volume":"8","author":"Panneer Selvam","year":"2015","journal-title":"Sci Signal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-167502","article-title":"Sphingosine-1-Phosphate Produced by Sphingosine Kinase 2 in Mitochondria Interacts With Prohibitin 2 to Regulate Complex IV Assembly and Respiration","volume":"25","author":"Strub","year":"2011","journal-title":"FASEB J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301741200","article-title":"Role of Human Sphingosine-1-Phosphate Phosphatase 1 in the Regulation of Intra- and Extracellular Sphingosine-1-Phosphate Levels and Cell Viability","volume":"278","author":"Johnson","year":"2003","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.03.005","article-title":"Sphingosine-1-Phosphate Lyase in Immunity and Cancer: Silencing the Siren","volume":"13","author":"Bandhuvula","year":"2007","journal-title":"Trends Mol Med"},{"key":"B42","article-title":"The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Calcium Homeostasis","volume":"9","author":"Hinkovska-Galcheva","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176709","article-title":"Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R046300","article-title":"An Update on the Biology of Sphingosine 1-Phosphate Receptors","volume":"55","author":"Blaho","year":"2014","journal-title":"J Lipid Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01670-7","article-title":"Sphingosine-1-Phosphate: Signaling Inside and Out","volume":"476","author":"Spiegel","year":"2000","journal-title":"FEBS Lett"},{"key":"B46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/bj3490385","article-title":"Sphingosine 1-Phosphate Signalling in Mammalian Cells","volume":"349","author":"Pyne","year":"2000","journal-title":"Biochem J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine Kinase, Sphingosine-1-Phosphate, and Apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807336200","article-title":"Subcellular Origin of Sphingosine 1-Phosphate is Essential for its Toxic Effect in Lyase-Deficient Neurons","volume":"284","author":"Hagen","year":"2009","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506182200","article-title":"Regulation of Autophagy by Sphingosine Kinase 1 and its Role in Cell Survival During Nutrient Starvation","volume":"281","author":"Lavieu","year":"2006","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1096\/fj.09-135087","article-title":"Antiapoptotic Roles of Ceramide-Synthase-6-Generated C16-Ceramide via Selective Regulation of the ATF6\/CHOP Arm of ER-Stress-Response Pathways","volume":"24","author":"Senkal","year":"2010","journal-title":"FASEB J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2174\/187152011797655177","article-title":"Ceramide-Based Therapeutics for the Treatment of Cancer","volume":"11","author":"Barth","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M809500200","article-title":"Acid Beta-Glucosidase 1 Counteracts P38delta-Dependent Induction of Interleukin-6: Possible Role for Ceramide as an Anti-Inflammatory Lipid","volume":"284","author":"Kitatani","year":"2009","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M802790200","article-title":"Involvement of Acid Beta-Glucosidase 1 in the Salvage Pathway of Ceramide Formation","volume":"284","author":"Kitatani","year":"2009","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6741-1_8","article-title":"Ceramide-1-Phosphate in Cell Survival and Inflammatory Signaling","volume":"688","author":"Gomez-Munoz","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1586\/erm.10.31","article-title":"Bone Marrow Microenvironment in Myelomagenesis: Its Potential Role in Early Diagnosis","volume":"10","author":"Balakumaran","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"B56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s002770050203","article-title":"Stromal Abnormalities in Neoplastic Bone Marrow Diseases","volume":"73","author":"Duhrsen","year":"1996","journal-title":"Ann Hematol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone Marrow Niches in Haematological Malignancies","volume":"20","author":"Mendez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and Their Metabolism in Physiology and Disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"180705","DOI":"10.1155\/2012\/180705","article-title":"Sphingosine 1-Phosphate Distribution in Human Plasma: Associations With Lipid Profiles","volume":"2012","author":"Hammad","year":"2012","journal-title":"J Lipids"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-Protective Sphingosine-1-Phosphate Provided by HDL-Associated Apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1042\/bj3520809","article-title":"Interaction of Sphingosine 1-Phosphate With Plasma Components, Including Lipoproteins, Regulates the Lipid Receptor-Mediated Actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.185","article-title":"Conditioning for Hematopoietic Transplantation Activates the Complement Cascade and Induces a Proteolytic Environment in Bone Marrow: A Novel Role for Bioactive Lipids and Soluble C5b-C9 as Homing Factors","volume":"26","author":"Kim","year":"2012","journal-title":"Leukemia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/path.4066","article-title":"Sphingosine-1-Phosphate Activates Chemokine-Promoted Myeloma Cell Adhesion and Migration Involving Alpha4beta1 Integrin Function","volume":"229","author":"Garcia-Bernal","year":"2013","journal-title":"J Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29861","article-title":"Increased S1P Expression in Osteoclasts Enhances Bone Formation in an Animal Model of Paget's Disease","volume":"122","author":"Nagata","year":"2021","journal-title":"J Cell Biochem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-Phosphate as a Regulator of Osteoclast Differentiation and Osteoclast-Osteoblast Coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.04.001","article-title":"Osteoblast-Derived Sphingosine 1-Phosphate to Induce Proliferation and Confer Resistance to Therapeutics to Bone Metastasis-Derived Prostate Cancer Cells","volume":"8","author":"Brizuela","year":"2014","journal-title":"Mol Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108662","article-title":"Mesenchymal Stromal Cell Secreted Sphingosine 1-Phosphate (S1P) Exerts a Stimulatory Effect on Skeletal Myoblast Proliferation","volume":"9","author":"Sassoli","year":"2014","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60746","article-title":"The Sphingosine-1-Phosphate Transporter Spns2 Expressed on Endothelial Cells Regulates Lymphocyte Trafficking in Mice","volume":"122","author":"Fukuhara","year":"2012","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(00)00084-X","article-title":"Sphingosine 1-Phosphate Signalling via the Endothelial Differentiation Gene Family of G-Protein-Coupled Receptors","volume":"88","author":"Pyne","year":"2000","journal-title":"Pharmacol Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e06-12-1096","article-title":"Tumor Cell Apoptosis Polarizes Macrophages Role of Sphingosine-1-Phosphate","volume":"18","author":"Weigert","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1541-7786.MCR-12-0600","article-title":"Bioactive Lipids S1P and C1P are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio\/Chemotherapy","volume":"11","author":"Schneider","year":"2013","journal-title":"Mol Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jbo.2018.09.001","article-title":"Osteoblast Suppression in Multiple Myeloma Bone Disease","volume":"13","author":"Adamik","year":"2018","journal-title":"J Bone Oncol"},{"key":"B73","first-page":"177","article-title":"The Pathology of Gaucher Disease","volume":"95","author":"Lee","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms20040843","article-title":"Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development","volume":"20","author":"Watek","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased Incidence of Cancer in Adult Gaucher Disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of Malignancies Among Patients With Type I Gaucher Disease From a Single Referral Clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2003.10.007","article-title":"Effect of Enzyme Replacement Therapy on Gammopathies in Gaucher Disease","volume":"32","author":"Brautbar","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and Free Light Chain Abnormalities in Gaucher Disease Type I: Data From an Adult Cohort of 63 Patients and Review of the Literature","volume":"87","author":"de Fost","year":"2008","journal-title":"Ann Hematol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000218","article-title":"Acquired Obesity is Associated With Changes in the Serum Lipidomic Profile Independent of Genetic Effects\u2013a Monozygotic Twin Study","volume":"2","author":"Pietilainen","year":"2007","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple Myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.062760","article-title":"Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer","volume":"309","author":"Struckhoff","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2013005814","article-title":"Gaucher's Disease and Cancer: A Sphingolipid Perspective","volume":"18","author":"Barth","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11.2.14624","article-title":"Dysregulation of Sphingolipid Metabolism in Cancer","volume":"11","author":"Ryland","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.04.001","article-title":"Metabolism of Short-Chain Ceramide by Human Cancer Cells\u2013Implications for Therapeutic Approaches","volume":"80","author":"Chapman","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2329","article-title":"Glucosylceramide Synthase Blockade Down-Regulates P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Cancer Cells to Anticancer Drugs","volume":"65","author":"Gouaze","year":"2005","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.10.11.13438","article-title":"Inhibition of NADPH Oxidase by Glucosylceramide Confers Chemoresistance","volume":"10","author":"Barth","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2007.09.005","article-title":"Ceramide and Glucosylceramide Upregulate Expression of the Multidrug Resistance Gene MDR1 in Cancer Cells","volume":"1771","author":"Gouaze-Andersson","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1476-4598-9-145","article-title":"Glucosylceramide Synthase Upregulates MDR1 Expression in the Regulation of Cancer Drug Resistance Through Csrc and Beta-Catenin Signaling","volume":"9","author":"Liu","year":"2010","journal-title":"Mol Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/path.4452","article-title":"Inhibition of UDP-Glucosylceramide Synthase in Mice Prevents Gaucher Disease-Associated B-Cell Malignancy","volume":"235","author":"Pavlova","year":"2015","journal-title":"J Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal Immunoglobulin Against Lysolipids in the Origin of Myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376236","article-title":"Dendritic Cell-Mediated Activation-Induced Cytidine Deaminase (AID)-Dependent Induction of Genomic Instability in Human Myeloma","volume":"119","author":"Koduru","year":"2012","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-220285","article-title":"Macrophages are an Abundant Component of Myeloma Microenvironment and Protect Myeloma Cells From Chemotherapy Drug-Induced Apoptosis","volume":"114","author":"Zheng","year":"2009","journal-title":"Blood"},{"key":"B93","first-page":"727","article-title":"Pseudo-Gaucher Plasma Cells in the Bone Marrow of a Patient With Monoclonal Gammopathy of Undetermined Significance","volume":"82","author":"Regazzoli","year":"1997","journal-title":"Haematologica"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1177\/1066896907311120","article-title":"Pseudo-Gaucher Cells in Multiple Myeloma","volume":"16","author":"Shenjere","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12259","article-title":"Role of Tumor-Associated Macrophages in Hematological Malignancies","volume":"65","author":"Komohara","year":"2015","journal-title":"Pathol Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00212","article-title":"Anatomy of a Discovery: M1 and M2 Macrophages","volume":"6","author":"Mills","year":"2015","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.06.003","article-title":"The Novel Biomarker of Alternative Macrophage Activation, Soluble Mannose Receptor (sMR\/Scd206): Implications in Multiple Myeloma","volume":"39","author":"Andersen","year":"2015","journal-title":"Leuk Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30102","article-title":"High Numbers of CD163+ Tumor-Associated Macrophages Correlate With Poor Prognosis in Multiple Myeloma Patients Receiving Bortezomib-Based Regimens","volume":"10","author":"Wang","year":"2019","journal-title":"J Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1652-6","article-title":"Tumor-Associated Macrophages as a Prognostic Parameter in Multiple Myeloma","volume":"92","author":"Suyani","year":"2013","journal-title":"Ann Hematol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.191","article-title":"Tumor-Associated Macrophages and Extracellular Matrix Metalloproteinase Inducer in Prognosis of Multiple Myeloma","volume":"30","author":"Panchabhai","year":"2016","journal-title":"Leukemia"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.3390\/cancers13143597","article-title":"The Role of Tumor-Associated Macrophages in Hematologic Malignancies","volume":"13","author":"Cencini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.55","article-title":"The Role of Monocytes-Macrophages in Vasculogenesis in Multiple Myeloma","volume":"23","author":"Ribatti","year":"2009","journal-title":"Leukemia"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210691","article-title":"Vasculogenic Mimicry by Bone Marrow Macrophages in Patients With Multiple Myeloma","volume":"27","author":"Scavelli","year":"2008","journal-title":"Oncogene"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2207","article-title":"Multiple Myeloma Cells Recruit Tumor-Supportive Macrophages Through the CXCR4\/CXCL12 Axis and Promote Their Polarization Toward the M2 Phenotype","volume":"5","author":"Beider","year":"2014","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/path.4860","article-title":"Tumour-Associated Macrophage-Mediated Survival of Myeloma Cells Through STAT3 Activation","volume":"241","author":"De Beule","year":"2017","journal-title":"J Pathol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12296","article-title":"Monocyte\/macrophage-Derived Soluble CD163: A Novel Biomarker in Multiple Myeloma","volume":"93","author":"Andersen","year":"2014","journal-title":"Eur J Haematol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and Lipid Metabolism","volume":"330","author":"Remmerie","year":"2018","journal-title":"Cell Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41419-021-03616-9","article-title":"Ceramides and Sphingosine-1-Phosphate Mediate the Distinct Effects of M1\/M2-Macrophage Infusion on Liver Recovery After Hepatectomy","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal Gammopathy of Undetermined Significance (MGUS) Consistently Precedes Multiple Myeloma: A Prospective Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC Dysregulation in the Progression of Multiple Myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1101\/gad.189365.112","article-title":"Links Between Metabolism and Cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Genes Dev"},{"key":"B116","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.85","article-title":"Alterations in Bone Marrow Metabolism are an Early and Consistent Feature During the Development of MGUS and Multiple Myeloma","volume":"5","author":"Ludwig","year":"2015","journal-title":"Blood Cancer J"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00884","article-title":"Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma","volume":"9","author":"Du","year":"2018","journal-title":"Front Pharmacol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2917","article-title":"Multiple Myeloma Patients Have a Specific Serum Metabolomic Profile That Changes After Achieving Complete Remission","volume":"19","author":"Puchades-Carrasco","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202045","article-title":"The Metabolomic Plasma Profile of Myeloma Patients Is Considerably Different From Healthy Subjects and Reveals Potential New Therapeutic Targets","volume":"13","author":"Steiner","year":"2018","journal-title":"PLoS One"},{"key":"B121","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1038\/s41598-020-67105-3","article-title":"Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients With Monoclonal Gammopathy of Undetermined Significance From Multiple Myeloma","volume":"10","author":"Gonsalves","year":"2020","journal-title":"Sci Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.118","article-title":"The Ceramide Pathway is Involved in the Survival, Apoptosis and Exosome Functions of Human Multiple Myeloma Cells In Vitro","volume":"39","author":"Cheng","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153124","article-title":"Ceramide Triggers Budding of Exosome Vesicles Into Multivesicular Endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding Light on the Cell Biology of Extracellular Vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200282","article-title":"The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function","volume":"189","author":"Nijnik","year":"2012","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2875","article-title":"Sphingosine 1-Phosphate and Cancer","volume":"10","author":"Pyne","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B127","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-7091-1511-4_3","article-title":"New Perspectives on the Role of Sphingosine 1-Phosphate in Cancer","author":"Pyne","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1084\/jem.20040559","article-title":"Phosphorylation-Dependent Translocation of Sphingosine Kinase to the Plasma Membrane Drives its Oncogenic Signalling","volume":"201","author":"Pitson","year":"2005","journal-title":"J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600028200","article-title":"Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives","volume":"282","author":"Spiegel","year":"2007","journal-title":"J Biol Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg540","article-title":"Activation of Sphingosine Kinase 1 by ERK1\/2-Mediated Phosphorylation","volume":"22","author":"Pitson","year":"2003","journal-title":"EMBO J"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/science.1057559","article-title":"Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility","volume":"291","author":"Hobson","year":"2001","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.22.7758-7768.2002","article-title":"Sphingosine Kinase Mediates Vascular Endothelial Growth Factor-Induced Activation of Ras and Mitogen-Activated Protein Kinases","volume":"22","author":"Shu","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.08.055","article-title":"Sphingosine Kinase 1 is Required for Migration, Proliferation and Survival of MCF-7 Human Breast Cancer Cells","volume":"579","author":"Sarkar","year":"2005","journal-title":"FEBS Lett"},{"key":"B134","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.yexcr.2004.04.049","article-title":"Sphingosine Kinase Activation Regulates Hepatocyte Growth Factor Induced Migration of Endothelial Cells","volume":"298","author":"Duan","year":"2004","journal-title":"Exp Cell Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1074\/jbc.M111423200","article-title":"Sphingosine Kinase Interacts With TRAF2 and Dissects Tumor Necrosis Factor-Alpha Signaling","volume":"277","author":"Xia","year":"2002","journal-title":"J Biol Chem"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1038com","article-title":"The Sphingosine Kinase 1\/Sphingosine-1-Phosphate Pathway Mediates COX-2 Induction and PGE2 Production in Response to TNF-Alpha","volume":"17","author":"Pettus","year":"2003","journal-title":"FASEB J"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06711.x","article-title":"Activation of Sphingosine Kinase Mediates Suppressive Effect of Interleukin-6 on Human Multiple Myeloma Cell Apoptosis","volume":"138","author":"Li","year":"2007","journal-title":"Br J Haematol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0119","article-title":"Sphingosine Kinase Transmits Estrogen Signaling in Human Breast Cancer Cells","volume":"17","author":"Sukocheva","year":"2003","journal-title":"Mol Endocrinol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01049-9","article-title":"Sphingosine Kinase-Mediated Calcium Signaling by Muscarinic Acetylcholine Receptors","volume":"68","author":"van Koppen","year":"2001","journal-title":"Life Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394274-6.00005-4","article-title":"Hypoxia, Therapeutic Resistance, and Sphingosine 1-Phosphate","volume":"117","author":"Cuvillier","year":"2013","journal-title":"Adv Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00789-0","article-title":"Stimulation of Intracellular Sphingosine-1-Phosphate Production by G-Protein-Coupled Sphingosine-1-Phosphate Receptors","volume":"414","author":"Meyer zu Heringdorf","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-Phosphate: An Enigmatic Signalling Lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4412fje","article-title":"Loss of Sphingosine Kinase-1 Activates the Intrinsic Pathway of Programmed Cell Death: Modulation of Sphingolipid Levels and the Induction of Apoptosis","volume":"20","author":"Taha","year":"2006","journal-title":"FASEB J"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2007.07.005","article-title":"Autocrine and Paracrine Roles of Sphingosine-1-Phosphate","volume":"18","author":"Alvarez","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2008.06.007","article-title":"The Role of Sphingosine Kinase 1 in Cancer: Oncogene or non-Oncogene Addiction","volume":"1781","author":"Vadas","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609559200","article-title":"Sphingosine Kinase Type 2 Activation by ERK-Mediated Phosphorylation","volume":"282","author":"Hait","year":"2007","journal-title":"J Biol Chem"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7792","article-title":"Extracellular Vesicle Cross-Talk in the Bone Marrow Microenvironment: Implications in Multiple Myeloma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by Extracellular Vesicles: Where We Are and Where We Need to Go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"B149","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.3390\/ijms20236048","article-title":"Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma","volume":"20","author":"Watek","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)67133-9","article-title":"Sphingosine Inhibition of Protein Kinase C Activity and of Phorbol Dibutyrate Binding In Vitro and in Human Platelets","volume":"261","author":"Hannun","year":"1986","journal-title":"J Biol Chem"},{"key":"B151","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-Orchestrated Signalling in Cancer Cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061289","article-title":"Plasma Cell S1P1 Expression Determines Secondary Lymphoid Organ Retention Versus Bone Marrow Tropism","volume":"203","author":"Kabashima","year":"2006","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.53","article-title":"Novel Insight Into Stem Cell Mobilization-Plasma Sphingosine-1-Phosphate Is a Major Chemoattractant That Directs the Egress of Hematopoietic Stem Progenitor Cells From the Bone Marrow and its Level in Peripheral Blood Increases During Mobilization Due to Activation of Complement Cascade\/Membrane Attack Complex","volume":"24","author":"Ratajczak","year":"2010","journal-title":"Leukemia"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/path.1876","article-title":"Role of Metalloproteinases MMP-9 and MT1-MMP in CXCL12-Promoted Myeloma Cell Invasion Across Basement Membranes","volume":"208","author":"Parmo-Cabanas","year":"2006","journal-title":"J Pathol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.2.346","article-title":"Chemokine Stromal Cell-Derived Factor-1alpha Modulates VLA-4 Integrin-Mediated Multiple Myeloma Cell Adhesion to CS-1\/Fibronectin and VCAM-1","volume":"97","author":"Sanz-Rodriguez","year":"2001","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0236","article-title":"Anti-Alpha4 Integrin Antibody Suppresses the Development of Multiple Myeloma and Associated Osteoclastic Osteolysis","volume":"104","author":"Mori","year":"2004","journal-title":"Blood"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092210","article-title":"S1P1 Receptor Directs the Release of Immature B Cells From Bone Marrow Into Blood","volume":"207","author":"Allende","year":"2010","journal-title":"J Exp Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20094","article-title":"G Protein Mediated Signaling Pathways in Lysophospholipid Induced Cell Proliferation and Survival","volume":"92","author":"Radeff-Huang","year":"2004","journal-title":"J Cell Biochem"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(02)00142-7","article-title":"Pathways of Transduction Engaged by Sphingosine 1-Phosphate Through G Protein-Coupled Receptors","volume":"1582","author":"Siehler","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"B160","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbalip.2004.01.006","article-title":"Sphingosine-1-Phosphate Receptors: Receptor Specificity Versus Functional Redundancy","volume":"1682","author":"Taha","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.04.037","article-title":"Sphingosine 1-Phosphate Induces Mcl-1 Upregulation and Protects Multiple Myeloma Cells Against Apoptosis","volume":"371","author":"Li","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-016-2854-3","article-title":"The Effect of S1P Receptor Signaling Pathway on the Survival and Drug Resistance in Multiple Myeloma Cells","volume":"424","author":"Fu","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"B163","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13045-018-0666-5","article-title":"Growth Factor Independence 1 Expression in Myeloma Cells Enhances Their Growth, Survival, and Osteoclastogenesis","volume":"11","author":"Petrusca","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-559385","article-title":"Inhibition of Sphingosine Kinase 2 Downregulates the Expression of C-Myc and Mcl-1 and Induces Apoptosis in Multiple Myeloma","volume":"124","author":"Venkata","year":"2014","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-021-01104-3","article-title":"The Biogenesis and Biological Function of PIWI-Interacting RNA in Cancer","volume":"14","author":"Chen","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00438","article-title":"PIWI-Interacting RNA-004800 Is Regulated by S1P Receptor Signaling Pathway to Keep Myeloma Cell Survival","volume":"10","author":"Ma","year":"2020","journal-title":"Front Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59987","article-title":"Glycosphingolipid Synthesis Inhibition Limits Osteoclast Activation and Myeloma Bone Disease","volume":"125","author":"Ersek","year":"2015","journal-title":"J Clin Invest"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-017-9571-8","article-title":"Endothelial Progenitor Cells in Multiple Myeloma Neovascularization: A Brick to the Wall","volume":"20","author":"Tenreiro","year":"2017","journal-title":"Angiogenesis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1159\/000046612","article-title":"Bone Marrow Angiogenesis and Plasma Cell Angiogenic and Invasive Potential in Patients With Active Multiple Myeloma","volume":"106","author":"Vacca","year":"2001","journal-title":"Acta Haematol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.02.017","article-title":"Angiogenesis in Multiple Myeloma","volume":"42","author":"Jakob","year":"2006","journal-title":"Eur J Cancer"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2006.09.008","article-title":"Sphingosine-1-Phosphate Signaling in the Cardiovascular System","volume":"7","author":"Peters","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G Protein-Coupled Receptor for Sphingosine-1-Phosphate, is Essential for Vascular Maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential Role for Sphingosine Kinases in Neural and Vascular Development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3679","article-title":"Thalidomide-Induced Antiangiogenic Action is Mediated by Ceramide Through Depletion of VEGF Receptors, and is Antagonized by Sphingosine-1-Phosphate","volume":"106","author":"Yabu","year":"2005","journal-title":"Blood"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach","volume":"29","author":"Blade","year":"2011","journal-title":"J Clin Oncol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802657751","article-title":"The Impact of Extramedullary Disease at Presentation on the Outcome of Myeloma","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13623","article-title":"Single-Cell RNA Sequencing Reveals Chemokine Self-Feeding of Myeloma Cells Promotes Extramedullary Metastasis","volume":"594","author":"Geng","year":"2020","journal-title":"FEBS Lett"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-662635","article-title":"The Hematopoietic Oncoprotein FOXP1 Promotes Tumor Cell Survival in Diffuse Large B-Cell Lymphoma by Repressing S1PR2 Signaling","volume":"127","author":"Flori","year":"2016","journal-title":"Blood"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S237330","article-title":"S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-kappaB Activation","volume":"12","author":"Pang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/nri3369","article-title":"Invariant Natural Killer T Cells: An Innate Activation Scheme Linked to Diverse Effector Functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2009.10.004","article-title":"Antigen Recognition by CD1d-Restricted NKT T Cell Receptors","volume":"22","author":"Godfrey","year":"2010","journal-title":"Semin Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The Biology of NKT Cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00384","article-title":"Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy","volume":"9","author":"Wolf","year":"2018","journal-title":"Front Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021650","article-title":"A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161281","article-title":"Regulation of Multiple Myeloma Survival and Progression by CD1d","volume":"113","author":"Spanoudakis","year":"2009","journal-title":"Blood"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.12.010","article-title":"Harnessing Natural Killer T (NKT) Cells in Human Myeloma: Progress and Challenges","volume":"140","author":"Dhodapkar","year":"2011","journal-title":"Clin Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98259","article-title":"Antigen-Mediated Regulation in Monoclonal Gammopathies and Myeloma","volume":"3","author":"Nair","year":"2018","journal-title":"JCI Insight"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1008850","article-title":"Modifications of the Mouse Bone Marrow Microenvironment Favor Angiogenesis and Correlate With Disease Progression From Asymptomatic to Symptomatic Multiple Myeloma","volume":"4","author":"Calcinotto","year":"2015","journal-title":"Oncoimmunology"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4523","article-title":"Chemokines CCL2, 3, 14 Stimulate Macrophage Bone Marrow Homing, Proliferation, and Polarization in Multiple Myeloma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.599098","article-title":"Actors on the Scene: Immune Cells in the Myeloma Niche","volume":"10","author":"Leone","year":"2020","journal-title":"Front Oncol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0487","article-title":"Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy","volume":"17","author":"Beyar-Katz","year":"2019","journal-title":"Mol Cancer Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09154.x","article-title":"Macrophages and Mesenchymal Stromal Cells Support Survival and Proliferation of Multiple Myeloma Cells","volume":"158","author":"Kim","year":"2012","journal-title":"Br J Haematol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24594","article-title":"Sphingosine Kinase 2 Deficient Tumor Xenografts Show Impaired Growth and Fail to Polarize Macrophages Towards an Anti-Inflammatory Phenotype","volume":"125","author":"Weigert","year":"2009","journal-title":"Int J Cancer"},{"key":"B194","first-page":"121","article-title":"Regulation of Immune Cell Migration by Sphingosine-1-Phosphate","volume":"61","author":"Kumar","year":"2015","journal-title":"Cell Mol Biol (OMICS)"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939858","article-title":"S1P3 Confers Differential S1P-Induced Migration by Autoreactive and non-Autoreactive Immature B Cells and is Required for Normal B-Cell Development","volume":"40","author":"Donovan","year":"2010","journal-title":"Eur J Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.807636","article-title":"The Role of Sphingolipids Metabolism in Cancer Drug Resistance","volume":"11","author":"Bataller","year":"2021","journal-title":"Front Oncol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-092981","article-title":"A Role for Ceramide in Driving Cancer Cell Resistance to Doxorubicin","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00074","article-title":"Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma","volume":"4","author":"Mynott","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00200","article-title":"Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells","volume":"4","author":"Mynott","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.6968","article-title":"The PI3K\/AKT Signaling Pathway Regulates ABCG2 Expression and Confers Resistance to Chemotherapy in Human Multiple Myeloma","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol Rep"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 Expression, Function, and Promoter Methylation in Human Multiple Myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2015.0118","article-title":"Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies","volume":"38","author":"Kitatani","year":"2015","journal-title":"Mol Cells"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.207704","article-title":"A Metabolic Switch in Proteasome Inhibitor-Resistant Multiple Myeloma Ensures Higher Mitochondrial Metabolism, Protein Folding and Sphingomyelin Synthesis","volume":"104","author":"Besse","year":"2019","journal-title":"Haematologica"},{"key":"B204","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.3390\/ijms22169001","article-title":"Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism","volume":"22","author":"Breiden","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/cancers11121823","article-title":"The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma","volume":"11","author":"Faict","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B206","doi-asserted-by":"publisher","first-page":"158630","DOI":"10.1016\/j.bbalip.2020.158630","article-title":"Novel Signaling Aspects of Ceramide 1-Phosphate","volume":"1865","author":"Presa","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B207","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.cellsig.2020.109860","article-title":"Alkaline Ceramidase Family: The First Two Decades","volume":"78","author":"Xu","year":"2021","journal-title":"Cell Signal"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17115","article-title":"Sphingosine Kinase 2 Inhibition Synergises With Bortezomib to Target Myeloma by Enhancing Endoplasmic Reticulum Stress","volume":"8","author":"Wallington-Beddoe","year":"2017","journal-title":"Oncotarget"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300772","article-title":"Sphingosine Kinase-1 and Sphingosine 1-Phosphate Receptor 2 Mediate Bcr-Abl1 Stability and Drug Resistance by Modulation of Protein Phosphatase 2A","volume":"117","author":"Salas","year":"2011","journal-title":"Blood"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1657","article-title":"miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13933","article-title":"Recent Advances in the Role of Sphingosine 1-Phosphate in Cancer","volume":"594","author":"Pyne","year":"2020","journal-title":"FEBS Lett"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2021.11.009","article-title":"Resensitising Proteasome Inhibitor-Resistant Myeloma With Sphingosine Kinase 2 Inhibition","volume":"24","author":"Bennett","year":"2022","journal-title":"Neoplasia"},{"key":"B213","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/ol.2022.13231","article-title":"Potential of a Sphingosine 1-Phosphate Receptor Antagonist and Sphingosine Kinase Inhibitors as Targets for Multiple Myeloma Treatment","volume":"23","author":"Tanaka","year":"2022","journal-title":"Oncol Lett"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400929","article-title":"Bcl-2, Bcl-X(L), and Bcl-W are Not Equivalent Targets of ABT-737 and Navitoclax (ABT-263) in Lymphoid and Leukemic Cells","volume":"119","author":"Merino","year":"2012","journal-title":"Blood"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20130147","article-title":"BAK Activation is Necessary and Sufficient to Drive Ceramide Synthase-Dependent Ceramide Accumulation Following Inhibition of BCL2-Like Proteins","volume":"452","author":"Beverly","year":"2013","journal-title":"Biochem J"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2009.04.022","article-title":"Fenretinide Inhibits Myeloma Cell Growth, Osteoclastogenesis and Osteoclast Viability","volume":"284","author":"Li","year":"2009","journal-title":"Cancer Lett"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.01.014","article-title":"Aromatase Inhibition by 15-Deoxy-Prostaglandin J(2) (15-dPGJ(2)) and N-(4-Hydroxyphenyl)-Retinamide (4HPR) is Associated With Enhanced Ceramide Production","volume":"94","author":"Andrews","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602212","article-title":"Fenretinide Stimulates Redox-Sensitive Ceramide Production in Breast Cancer Cells: Potential Role in Drug-Induced Cytotoxicity","volume":"91","author":"Rehman","year":"2004","journal-title":"Br J Cancer"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7145","article-title":"The Emerging Role of FTY720 (Fingolimod) in Cancer Treatment","volume":"7","author":"White","year":"2016","journal-title":"Oncotarget"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0850","article-title":"FTY720 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Drug Resistance","volume":"65","author":"Yasui","year":"2005","journal-title":"Cancer Res"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2011.12.014","article-title":"Autophagy Induced by FTY720 Promotes Apoptosis in U266 Cells","volume":"45","author":"Liao","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"B222","doi-asserted-by":"publisher","first-page":"118077","DOI":"10.1016\/j.lfs.2020.118077","article-title":"FTY720 Induces Ferroptosis and Autophagy via PP2A\/AMPK Pathway in Multiple Myeloma Cells","volume":"260","author":"Zhong","year":"2020","journal-title":"Life Sci"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2618","article-title":"The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4\/CXCL12 Pathway","volume":"23","author":"Beider","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B224","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1159\/000491908","article-title":"Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells","volume":"48","author":"Zhao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B225","doi-asserted-by":"publisher","first-page":"4397159","DOI":"10.1155\/2018\/4397159","article-title":"More Than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis","volume":"2018","author":"Takasaki","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B226","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbcan.2007.11.002","article-title":"Dissecting Lipid Raft Facilitated Cell Signaling Pathways in Cancer","volume":"1785","author":"Patra","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e13-09-0516","article-title":"Lipids in Cell Biology: How can We Understand Them Better","volume":"25","author":"Muro","year":"2014","journal-title":"Mol Biol Cell"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2765-4","article-title":"Lipids in the Cell: Organisation Regulates Function","volume":"75","author":"Santos","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.571237","article-title":"New Insights Into Targeting Membrane Lipids for Cancer Therapy","volume":"8","author":"Preta","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.3390\/ijms19123871","article-title":"Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies","volume":"19","author":"Bernardes","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B231","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/ijo.2016.3516","article-title":"Multiple Myeloma and Persistence of Drug Resistance in the Age of Novel Drugs (Review)","volume":"49","author":"Krishnan","year":"2016","journal-title":"Int J Oncol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00012","article-title":"Targeting Membrane Lipid a Potential Cancer Cure","volume":"8","author":"Tan","year":"2017","journal-title":"Front Pharmacol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.drup.2005.02.003","article-title":"Role of Early Plasma Membrane Events in Chemotherapy-Induced Cell Death","volume":"8","author":"Dimanche-Boitrel","year":"2005","journal-title":"Drug Resist Update"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111837","article-title":"Green Tea Polyphenol EGCG Induces Lipid-Raft Clustering and Apoptotic Cell Death by Activating Protein Kinase Cdelta and Acid Sphingomyelinase Through a 67 kDa Laminin Receptor in Multiple Myeloma Cells","volume":"443","author":"Tsukamoto","year":"2012","journal-title":"Biochem J"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0420","article-title":"Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640","volume":"151","author":"Antoon","year":"2010","journal-title":"Endocrinology"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044543","article-title":"Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-Gamma-Producing NKT Response Induced With Alpha-Galactosylceramide-Loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042592","article-title":"Sustained Expansion of NKT Cells and Antigen-Specific T Cells After Injection of Alpha-Galactosyl-Ceramide Loaded Mature Dendritic Cells in Cancer Patients","volume":"201","author":"Chang","year":"2005","journal-title":"J Exp Med"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-435503","article-title":"Clinical Regressions and Broad Immune Activation Following Combination Therapy Targeting Human NKT Cells in Myeloma","volume":"1","author":"Richter","year":"2013","journal-title":"Blood"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13092","article-title":"Stimulation of Invariant Natural Killer T Cells by Alpha-Galactosylceramide Activates the JAK-STAT Pathway in Endothelial Cells and Reduces Angiogenesis in the 5T33 Multiple Myeloma Model","volume":"167","author":"Nur","year":"2014","journal-title":"Br J Haematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.925807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T04:54:36Z","timestamp":1654664076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.925807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":241,"alternative-id":["10.3389\/fonc.2022.925807"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.925807","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"article-number":"925807"}}